Omnicell Inc. (OMCL)

52.10
0.05 0.10
NASDAQ : Technology Services
Prev Close 52.05
Open 52.35
Day Low/High 49.45 / 52.49
52 Wk Low/High 39.75 / 55.40
Volume 230.90K
Avg Volume 256.30K
Exchange NASDAQ
Shares Outstanding 38.88M
Market Cap 2.06B
EPS 0.60
P/E Ratio 58.94
Div & Yield N.A. (N.A)

Latest News

Omnicell To Showcase Industry-Leading Medication Management Automation Platform At Annual ASHP Summer Meeting

Solutions to Help Improve Visibility, Streamline Workflows, and Support Patient Safety on Display in Booth #701

VitalConnect Announces Joe Lynch As Chief Marketing Officer

Experienced medtech marketing leader to drive continuous patient monitoring market strategy

Sentara RMH Medical Center Partners With Omnicell To Enhance Efficiency, Safety In Central Pharmacy Operations

Leveraging Automation Frees Staff to Focus on Clinical Care

Interesting OMCL Put And Call Options For November 16th

Investors in Omnicell Inc saw new options become available this week, for the November 16th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 203 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Mercyhealth Adopts Omnicell's XR2 Automated Central Pharmacy System To Enhance Patient Safety

Mercyhealth Adopts Omnicell's XR2 Automated Central Pharmacy System To Enhance Patient Safety

Robotic Technology Automates Critical Workflows Across Health System and Dispensing Solutions

Omnicell To Showcase Industry-Leading Medication Management Automation Platform And Solutions At The European Association Of Hospital Pharmacists Congress

Omnicell To Showcase Industry-Leading Medication Management Automation Platform And Solutions At The European Association Of Hospital Pharmacists Congress

Scalable, Customizable, and Integrated Products to Improve Patient Safety and Reduce Costs on Display in Stand 75

Infirmary Health Adopts Omnicell's Sterile Compounding Solutions And Services

Infirmary Health Adopts Omnicell's Sterile Compounding Solutions And Services

Comprehensive turnkey solution supports safer, more cost-effective and efficient production of IVs

Omnicell Opens Center Of Excellence In Cranberry Township, Showcasing Innovation And Industry-Leading Medication Management Platform

Omnicell Opens Center Of Excellence In Cranberry Township, Showcasing Innovation And Industry-Leading Medication Management Platform

U.S. Representative Mike Kelly to Join Company Leadership for March 2 Dedication Ceremony

Omnicell's Industry-Leading Medication Management Automation Platform And Solutions To Be Featured At HIMSS18

Omnicell's Industry-Leading Medication Management Automation Platform And Solutions To Be Featured At HIMSS18

Scalable, Customizable, and Integrated Products to Improve Patient Safety and Reduce Costs on Display in Booth #1629

Pomona Valley Hospital Medical Center Adopting In-House IV Compounding With Omnicell's IV Robotics

Pomona Valley Hospital Medical Center Adopting In-House IV Compounding With Omnicell's IV Robotics

Investments in Automation Position Hospital for Long Term Savings and Patient Safety

Multiple Hospitals Adopt Omnicell's XR2 Automated Central Pharmacy System To Enhance Medication Inventory Management

Multiple Hospitals Adopt Omnicell's XR2 Automated Central Pharmacy System To Enhance Medication Inventory Management

Revolutionary Technology Automates Critical Workflows, Refocusing Pharmacists' Time on Clinical Activities

Omnicell's Automated Medication Dispensing System Receives Top KLAS Award For The 12th Consecutive Year

Omnicell's Automated Medication Dispensing System Receives Top KLAS Award For The 12th Consecutive Year

Company Also Recognized as Category Leader in Carousels, i.v.STATION Most Improved Medical Equipment Product

Dartmouth-Hitchcock Health Selects Omnicell's Performance Center To Help Develop Centralized Pharmacy Service Center

Dartmouth-Hitchcock Health Selects Omnicell's Performance Center To Help Develop Centralized Pharmacy Service Center

Enhanced Visibility and Ongoing Services Optimizes Inventory Management and Medication Ordering Across the Health System

Short Interest Decreases By 10.8% For OMCL

Short Interest Decreases By 10.8% For OMCL

The most recent short interest data has been released for the 10/31/2017 settlement date, which shows a 345,543 share decrease in total short interest for Omnicell Inc , to 2,866,560, a decrease of 10.76% since 10/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Signs of Consolidation After Buying Surge

Tesla bounces despite bad news.

Omnicell Reaches Analyst Target Price

Omnicell Reaches Analyst Target Price

In recent trading, shares of Omnicell Inc have crossed above the average analyst 12-month target price of $51.14, changing hands for $52.30/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

Short Interest Decreases By 10.8% For OMCL

Short Interest Decreases By 10.8% For OMCL

The most recent short interest data has been released for the 08/15/2017 settlement date, which shows a 419,471 share decrease in total short interest for Omnicell Inc , to 3,450,765, a decrease of 10.84% since 07/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ATRO, BLL, CCE, CSII, EGN, EMR, HCI, IMPV, K, MANT, MLCO, MX, OI, RDS.A, RDS.B, TPRE, USCR, WMC Downgrades: CCO, CLF, GCAP, INCY, KMPR, OMCL, OMI, SHEN, SWIR, UEPS Initiations: ORMP Read on to get TheStreet Quant Ratings' detailed report:

Short Interest In Omnicell Increases 15.6%

The most recent short interest data has been released for the 03/15/2017 settlement date, which shows a 538,618 share increase in total short interest for Omnicell Inc , to 3,984,297, an increase of 15.63% since 02/28/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ALKS, CCU, CRAY, CRNT, DX, ELMD, ESSA, NLY, OMCL, XEC Downgrades: ETR, RDCM Initiations: SGLB Read on to get TheStreet Quant Ratings' detailed report:

Omnicell Stock Sees Short Interest Increase 12.2%

The most recent short interest data has been released for the 01/31/2017 settlement date, which shows a 277,900 share increase in total short interest for Omnicell Inc , to 2,555,167, an increase of 12.20% since 01/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AXE, CECE, EMN, FC, NNI, PDCO, SAH, SAMG, WERN Downgrades: ATW, CERN, IPXL, NVO, OMCL, PHII, PHIIK, PLKI, SVT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Omnicell Stock Sees Short Interest Decrease By 20.2%

Omnicell Stock Sees Short Interest Decrease By 20.2%

The most recent short interest data has been released for the 07/29/2016 settlement date, which shows a 314,564 share decrease in total short interest for Omnicell Inc , to 1,243,238, a decrease of 20.19% since 07/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Insider Trading Alert - XPLR, ACET And OMCL Traded By Insiders

Insider Trading Alert - XPLR, ACET And OMCL Traded By Insiders

Stocks with insider trader activity include XPLR, ACET and OMCL

These Small-Cap Growth Stocks Look Ready to Pop

These Small-Cap Growth Stocks Look Ready to Pop

Four small-cap growth companies look like they're on sale now.

Insider Trading Alert - SON, GES And OMCL Traded By Insiders

Insider Trading Alert - SON, GES And OMCL Traded By Insiders

Stocks with insider trader activity include SON, GES and OMCL

RBC Capital Markets Likes These 13 Small-Cap Stocks for Your 2016 Portfolio

RBC Capital Markets Likes These 13 Small-Cap Stocks for Your 2016 Portfolio

Since this summer's market low, small-cap stocks have been outperforming large-cap stocks. Here are small caps with 'persistently strong top-line growth and improving fundamentals,' according to RBC Capital Markets.

TheStreet Quant Rating: C+ (Hold)